First Trust Advisors LP Sells 161,067 Shares of Teleflex Incorporated $TFX

by · The Markets Daily

First Trust Advisors LP cut its position in Teleflex Incorporated (NYSE:TFX – Free Report) by 98.4% in the 1st quarter, Holdings Channel reports. The institutional investor owned 2,616 shares of the medical technology company’s stock after selling 161,067 shares during the quarter. First Trust Advisors LP’s holdings in Teleflex were worth $313,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently made changes to their positions in TFX. Hsbc Holdings PLC grew its holdings in shares of Teleflex by 4.7% during the first quarter. Hsbc Holdings PLC now owns 1,861 shares of the medical technology company’s stock valued at $222,000 after buying an additional 84 shares during the last quarter. Banque Cantonale Vaudoise raised its holdings in Teleflex by 82.5% in the 4th quarter. Banque Cantonale Vaudoise now owns 250 shares of the medical technology company’s stock worth $31,000 after acquiring an additional 113 shares during the last quarter. Hantz Financial Services Inc. lifted its position in Teleflex by 40.5% in the 4th quarter. Hantz Financial Services Inc. now owns 392 shares of the medical technology company’s stock valued at $48,000 after acquiring an additional 113 shares in the last quarter. UMB Bank n.a. lifted its position in Teleflex by 57.1% in the 4th quarter. UMB Bank n.a. now owns 311 shares of the medical technology company’s stock valued at $38,000 after acquiring an additional 113 shares in the last quarter. Finally, Maryland State Retirement & Pension System boosted its stake in Teleflex by 1.5% during the 4th quarter. Maryland State Retirement & Pension System now owns 8,652 shares of the medical technology company’s stock valued at $1,056,000 after purchasing an additional 129 shares during the last quarter. Institutional investors own 95.62% of the company’s stock.

Analysts Set New Price Targets

A number of research firms have commented on TFX. Weiss Ratings reissued a “sell (d)” rating on shares of Teleflex in a report on Wednesday, June 24th. UBS Group upped their price target on Teleflex from $145.00 to $158.00 and gave the company a “neutral” rating in a report on Tuesday. Wall Street Zen raised Teleflex from a “sell” rating to a “hold” rating in a research report on Sunday. Zacks Research raised Teleflex from a “strong sell” rating to a “hold” rating in a research report on Tuesday, April 28th. Finally, BMO Capital Markets initiated coverage on shares of Teleflex in a research note on Wednesday, July 8th. They set an “outperform” rating and a $159.00 target price on the stock. One research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $151.80.

Get Our Latest Report on TFX

Teleflex Trading Up 1.5%

Shares of Teleflex stock opened at $135.55 on Thursday. Teleflex Incorporated has a 1-year low of $100.18 and a 1-year high of $145.00. The company’s fifty day simple moving average is $132.13 and its 200-day simple moving average is $123.34. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.60 and a quick ratio of 2.12. The stock has a market capitalization of $5.74 billion, a PE ratio of -5.82, a P/E/G ratio of 0.89 and a beta of 0.81.

Teleflex (NYSE:TFX – Get Free Report) last issued its quarterly earnings results on Thursday, August 6th. The medical technology company reported $1.76 EPS for the quarter, topping analysts’ consensus estimates of $1.28 by $0.48. The business had revenue of $570.33 million during the quarter, compared to analysts’ expectations of $559.59 million. Teleflex had a positive return on equity of 11.93% and a negative net margin of 39.67%.The business’s quarterly revenue was up 28.9% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.73 earnings per share. Teleflex has set its FY 2026 guidance at 6.900-7.200 EPS. As a group, equities analysts anticipate that Teleflex Incorporated will post 7.26 earnings per share for the current year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, September 30th. Shareholders of record on Friday, August 14th will be issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 1.0%. The ex-dividend date is Friday, August 14th. Teleflex’s payout ratio is currently -5.84%.

Teleflex Profile

(Free Report)

Teleflex Incorporated is a diversified global provider of medical technologies, specializing in critical care and surgery. Headquartered in Wayne, Pennsylvania, the company designs, manufactures and distributes devices and solutions used by healthcare professionals in hospital, ambulatory and alternate site settings. Teleflex focuses on delivering products that support complex interventional procedures and improve patient outcomes.

The company’s offerings span several key segments, including Interventional Urology, Respiratory & Anesthesia, Surgical, Cardiac Care, Vascular and Original Equipment Manufacturer (OEM) solutions.

Recommended Stories

Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX – Free Report).